Pressmeddelanden, rapporter och bolagsmeddelande för Curasight
Spotlight News
Nyhetsuppdatering från Curasight
Reports: Interim Report January – September 2023
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight A/S reports positive preclinical results with uTREAT[®] in lung cancer (NSCLC)
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Positive results from the Phase II study of uTRACE in brain cancer presented at the World Molecular Imaging Congress (WMIC) 2023 in Prague
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight to present at HC Andersen Capital and at HC Andersen Life Science seminar
Spotlight News
Nyhetsuppdatering från Curasight
Reports: Interim Report January – June 2023
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Positive results in uPAR-PET/MR Phase II study in brain cancer
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight A/S reports positive preclinical results with uTREAT[®] in aggressive brain cancer (glioblastoma)
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight to present at HC Andersen Capital and Økonomisk Ugebrev
Spotlight News
Nyhetsuppdatering från Curasight
Reports: Interim report Q1 2023
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight and Curium announce global partnership for uTRACE[®] in prostate cancer